The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity -: Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor γ and IκB kinase activities

被引:337
作者
Makowski, L
Brittingham, KC
Reynolds, JM
Suttles, J
Hotamisligil, GKS
机构
[1] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M413788200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatty acid-binding proteins are cytosolic fatty acid chaperones, and the adipocyte isoform, aP2, plays an important role in obesity and glucose metabolism. Recently, this protein has been detected in macrophages where it strongly contributes to the development of atherosclerosis. Here, we investigated the role of aP2 in macrophage biology and the molecular mechanisms underlying its actions. We demonstrate that aP2-deficient macrophages display defects in cholesterol accumulation and alterations in pro-inflammatory responsiveness. Deficiency of aP2 alters the lipid composition in macrophages and enhances peroxisome proliferator-activated receptor gamma activity, leading to elevated CD36 expression and enhanced uptake of modified low density lipoprotein. The increased peroxisome proliferator-activated receptor gamma activity in aP2-deficient macrophages is also accompanied by a significant stimulation of the liver X receptor alpha-ATP-binding cassette transporter A1-mediated cholesterol efflux pathway. In parallel, aP2-deficient macrophages display reduced I kappa B kinase and NF-kappa B activity, resulting in suppression of inflammatory function including reduced cyclooxygenase-2 and inducible nitric-oxide synthase expression and impaired production of inflammatory cytokines. Our results demonstrate that aP2 regulates two central molecular pathways to coordinate macrophage cholesterol trafficking and inflammatory activity.
引用
收藏
页码:12888 / 12895
页数:8
相关论文
共 49 条
[31]   Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis [J].
Makowski, L ;
Boord, JB ;
Maeda, K ;
Babaev, VR ;
Uysal, KT ;
Morgan, MA ;
Parker, RA ;
Suttles, J ;
Fazio, S ;
Hotamisligil, GS ;
Linton, MF .
NATURE MEDICINE, 2001, 7 (06) :699-705
[32]   Azotemia, TNF alpha, and LPS prime the human neutrophil oxidative burst by distinct mechanisms [J].
McLeish, KR ;
Klein, JB ;
Lederer, ED ;
Head, KZ ;
Ward, RA .
KIDNEY INTERNATIONAL, 1996, 50 (02) :407-416
[33]   The role of PPAR-γ in macrophage differentiation and cholesterol uptake [J].
Moore, KJ ;
Rosen, ED ;
Fitzgerald, ML ;
Randow, F ;
Andersson, LP ;
Altshuler, D ;
Milstone, DS ;
Mortensen, RM ;
Spiegelman, BM ;
Freeman, MW .
NATURE MEDICINE, 2001, 7 (01) :41-47
[34]   Oxidized LDL regulates macrophage gene expression through ligand activation of PPARγ [J].
Nagy, L ;
Tontonoz, P ;
Alvarez, JGA ;
Chen, HW ;
Evans, RM .
CELL, 1998, 93 (02) :229-240
[35]   PPARγ activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes [J].
Pelton, PD ;
Zhou, LB ;
Demarest, KT ;
Burris, TP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) :456-458
[36]   Cyclopentenone prostaglandins suppress activation of microglia:: Down-regulation of inducible nitric-oxide synthase by 15-deoxy-Δ12,14-prostaglandin J2 [J].
Petrova, TV ;
Akama, KT ;
Van Eldik, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4668-4673
[37]   Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ [J].
Repa, JJ ;
Liang, GS ;
Ou, JF ;
Bashmakov, Y ;
Lobaccaro, JMA ;
Shimomura, I ;
Shan, B ;
Brown, MS ;
Goldstein, JL ;
Mangelsdorf, DJ .
GENES & DEVELOPMENT, 2000, 14 (22) :2819-2830
[38]   The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation [J].
Ricote, M ;
Li, AC ;
Willson, TM ;
Kelly, CJ ;
Glass, CK .
NATURE, 1998, 391 (6662) :79-82
[39]   Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase [J].
Rossi, A ;
Kapahi, P ;
Natoli, G ;
Takahashi, T ;
Chen, Y ;
Karin, M ;
Santoro, MG .
NATURE, 2000, 403 (6765) :103-108
[40]   Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice [J].
Scheja, L ;
Makowski, L ;
Uysal, KT ;
Wiesbrock, SM ;
Shimshek, DR ;
Meyers, DS ;
Morgan, M ;
Parker, RA ;
Hotamisligil, GS .
DIABETES, 1999, 48 (10) :1987-1994